Product Information
OXYBUTYNIN CL ER 5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0875 per EA under NDC 68382025501. Its NADAC has been published 425 times since May 9, 2018.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382025501
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202332On Market Since
8/10/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 5 MG TABLET has been published 425 times since May 9, 2018, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0875 per EA |
|---|---|
| All-time high | $0.4449 (Jul 11, 2018) |
| All-time low | $0.0765 (Nov 20, 2024) |
| 52-week high | $0.0990 |
| 52-week low | $0.0875 |
| Median price | $0.1389 |
| Average price | $0.1869 |
| Largest weekly change | +35.7% (Jun 19, 2024) |
| Weeks tracked | 425 |
| Tracking since | May 9, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0875 per EA (NDC 68382025501), effective Jun 24, 2026.
How has the price of OXYBUTYNIN CL ER 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has declined 79.9%. It has been tracked across 425 weekly CMS publications since May 9, 2018.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 5 MG TABLET?
Since May 9, 2018, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has ranged from a low of $0.0765 (Nov 20, 2024) to a high of $0.4449 (Jul 11, 2018), with a median of $0.1389 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OXYBUTYNIN CL ER 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN CL ER 5 MG TABLET?
OXYBUTYNIN CL ER 5 MG TABLET (NDC 68382025501) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification